MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease

O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov (Chisinau, Republic of Moldova)

Meeting: 2023 International Congress

Abstract Number: 1390

Keywords: Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: Objective of this study was to investigate the potential correlation between hemoglobin levels and Parkinson’s disease (PD) severity, and to compare them with a control group of healthy individuals.

Background: Previous studies have suggested a possible link between anemia and Parkinson’s disease (PD). Some studies found that low hemoglobin (Hb) levels were associated with an increased risk of PD. However, the relationship between Hb levels and PD severity is not well understood.

Method: This study included 58 patients with PD (56.9% female, 43.1% male) and 70 healthy controls. Hb levels were measured and compared between different stages of disease severity as measured by the Hoehn and Yahr (H&Y) scale, UPDRS III and between the PD group and the control group. Statistical analyses included the Mann-Whitney test, Kruskal-Wallis test, and Spearman’s correlation test.

Results: The PD group and control group were homogeneous with respect to age (p=0.9). Hb levels did not differ significantly between the different stages of disease severity (p=0.516) or between the PD group and the control group (p=0.7). Additionally, there was no significant correlation between Hb levels and disease severity as measured by the UPDRS III (r=0.3, p=0.6).

Conclusion: These results suggest that Hb level is not significantly correlated with disease severity in patients with PD. However, further research with larger sample sizes is needed to confirm these findings and to better understand the relationship between Hb levels and PD.

To cite this abstract in AMA style:

O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov. Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/correlation-between-hemoglobin-level-and-disease-severity-in-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/correlation-between-hemoglobin-level-and-disease-severity-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley